Stress, Cortisol, and Hives: What the Research Shows About Chronic Urticaria Flares

Hives, known medically as urticaria, are raised, itchy welts that appear and fade on the skin, sometimes with deeper swelling called angioedema. Acute hives are very common and often have an identifiable trigger such as an infection, a medication, or a food. When hives keep returning for six weeks or longer without a clear external cause, the condition is called chronic spontaneous urticaria, and it is here that questions about stress come up most often, because many patients report that their worst flares line up with difficult periods in their lives.

The basic biology is well established. Urticaria is a mast cell driven condition: mast cells in the skin release histamine and other inflammatory signals, which cause the leaking blood vessels and itch behind each welt. International guidelines from EAACI, GA²LEN, and partner societies describe chronic spontaneous urticaria in these terms and note that, in a substantial share of patients, an autoimmune process activates mast cells. Mast cells also respond to stress-related signals from nerves and the HPA axis, which gives researchers a plausible pathway linking psychological stress to flares.

The research on stress itself is fairly consistent. Studies of people with chronic urticaria regularly find higher rates of stressful life events, anxiety, and poorer quality of life than in comparison groups, and patients frequently name stress as a trigger. The cortisol findings, though, are less tidy than wellness content suggests. A 2016 study in the Annals of Allergy, Asthma & Immunology with 45 chronic urticaria patients found higher stress scores and markers of inflammation alongside lower basal cortisol than in healthy controls, with lower cortisol associated with longer and more severe disease. A 2025 study in the International Journal of Molecular Sciences, by contrast, found higher serum cortisol in 23 patients with chronic spontaneous urticaria than in controls, with cortisol tracking disease severity, even though these patients reported lower perceived stress.

Those conflicting results are not necessarily contradictory. Both studies were small, measured cortisol at single points in time, and cannot show cause and effect. They are consistent with a broader idea that the stress system is dysregulated in some people with chronic hives, but they do not establish that cortisol is simply "too high" or "too low," or that fixing cortisol would fix the hives. It is also plausible that living with an unpredictable, itchy, visible condition is itself a significant source of stress, which makes the direction of the relationship hard to untangle.

This is where proven and trend part ways. Reasonably well supported: stress is a commonly reported flare trigger, chronic urticaria is associated with meaningful psychological burden, and the mast cell and HPA axis connection offers a credible mechanism. Trend and marketing territory: "cortisol-lowering" supplements, adrenal support blends, or detox protocols promoted as treatments for hives, none of which have been tested in controlled urticaria trials. Evidence-based care, as outlined in the international guideline, starts with second-generation non-sedating antihistamines, and when those are not enough, specialists can move to options such as the biologic omalizumab.

The realistic takeaway is that stress management is a reasonable part of living with chronic hives, especially for people who notice a clear link between tense periods and flares, and attention to anxiety or sleep can improve quality of life in its own right. It works best as a complement to proper medical treatment rather than a substitute. Anyone with hives lasting more than a few weeks, or with swelling of the lips, tongue, or throat, should see a clinician promptly.